GeneDx CEO Katherine Stueland likes the potential of newborn testing, but she says her Stamford, Connecticut, company is ...

A new blood test is designed to find mold infections deep inside the body, sparing patients from tissue biopsies.

The partnership with Lumea positions Myriad Genetics to reach a wider audience through Lumea's established market presence, potentially increasing the utilization of their diagnostic tests.

After a genetic test, Alex Swanson learned he has hereditary hemochromatosis, a condition causing iron overload that can lead ...

KBC Group NV raised its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 132.8% in the fourth quarter, ...

For instance, a diagnosis could change in the future ... For example, research has linked about 80 genes to Alzheimer’s. While genetic testing can identify the risky genes, that doesn’t ...

Storm "took a lot of abuse" as a young female sports journalist. Last year, she was stunned by a breast cancer diagnosis.

GAITHERSBURG, Md. - GeneDx (NASDAQ: WGS), a genomic insights company valued at $1.64 billion, has launched its services on Aura, Epic's specialty diagnostics suite, to facilitate advanced genetic ...

Genetic testing creates important opportunities for assessment of genetic risk and diagnosis. However, some genetic tests do not identify all of the possible gene mutations that can cause a ...

A new coverage determination will prevent Medicare patients with certain cancers from accessing genetic testing, a move that advocates and testing companies say will severely limit early interventions ...